Thuis > Producten > Tussenpersonen > N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide
N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide
  • N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamideN-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide

N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide

Productnaam: N-(5-Chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6 ,7-tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide
Molecuulformule: C24H30ClN7O4S
Molecuulgewicht: 548,06
CAS-registratienummer: 480449-70-5

Model:CAS NO:480449-70-5

Stuur onderzoek

Productomschrijving

Identificatie
Naam N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridine-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide
copyRight
Moleculaire structuur
Moleculaire formule
C24H30ClN7O4S
Moleculair gewicht 548.06
CAS-registratienummer 480449-70-5
Toepassing Edoxaban tussenproduct

Hottags: N-(5-chloorpyridine-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7- tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethaandiamide, China, leveranciers, fabrikanten, fabriek
Gerelateerde categorie
Stuur onderzoek
Stel gerust uw vraag via onderstaand formulier. Wij zullen u binnen 24 uur antwoorden.
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept